Literature DB >> 3584117

Analysis of thymidylate synthase gene amplification and of mRNA levels in the cell cycle.

A M Imam, P H Crossley, A L Jackman, P F Little.   

Abstract

We report that the gene for thymidylate synthase (TS) is amplified in the mouse cell line L1210:C15 that was selectively grown in increasing concentrations of the competitive inhibitor of thymidylate synthase, CB3717. The gene is amplified 50-fold compared to the parental cell line. Amplification has not been accompanied by any major rearrangements, and the increase in gene copy number is reflected in elevation of thymidylate synthase mRNA levels. The amplification is relatively stable as there was only a 2- to 3-fold decrease in the number of amplified TS genes when cells were grown in the absence of selection for 375 generations. We also observe a 30- to 40-fold increase in number of copies of the dihydrofolate reductase gene with 7-fold elevation of the RNA product, and we suggest that this may be due to cross-inhibition of dihydrofolate reductase by CB3717. Thymidylate synthase mRNA levels in L1210 and L1210:C15 show no variation within the different phases of the cell cycle but are significantly reduced during quiescence.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3584117

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Regulation of thymidine kinase protein levels during myogenic withdrawal from the cell cycle is independent of mRNA regulation.

Authors:  M K Gross; G F Merrill
Journal:  Nucleic Acids Res       Date:  1988-12-23       Impact factor: 16.971

2.  Identification of an RNA binding site for human thymidylate synthase.

Authors:  E Chu; D Voeller; D M Koeller; J C Drake; C H Takimoto; G F Maley; F Maley; C J Allegra
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

3.  A cell cycle analysis of growth-related genes expressed during T lymphocyte maturation.

Authors:  J N Feder; C J Guidos; B Kusler; C Carswell; D Lewis; R T Schimke
Journal:  J Cell Biol       Date:  1990-12       Impact factor: 10.539

4.  Molecular characterisation of two cell lines selected for resistance to the folate-based thymidylate synthase inhibitor, ZD1694.

Authors:  S J Freemantle; A L Jackman; L R Kelland; A H Calvert; J Lunec
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

5.  Thymidylate synthase expression and activity: relation to S-phase parameters and 5-fluorouracil sensitivity.

Authors:  J F Mirjolet; M Barberi-Heyob; J L Merlin; S Marchal; M C Etienne; G Milano; P Bey
Journal:  Br J Cancer       Date:  1998-07       Impact factor: 7.640

6.  Mechanisms of acquired resistance to the quinazoline thymidylate synthase inhibitor ZD1694 (Tomudex) in one mouse and three human cell lines.

Authors:  A L Jackman; L R Kelland; R Kimbell; M Brown; W Gibson; G W Aherne; A Hardcastle; F T Boyle
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

7.  Effect of hammerhead ribozyme against human thymidylate synthase on the cytotoxicity of thymidylate synthase inhibitors.

Authors:  H Kobayashi; Y Takemura; H Miyachi; L Skelton; A L Jackman
Journal:  Jpn J Cancer Res       Date:  1995-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.